000 00901 a2200253 4500
005 20250517190151.0
264 0 _c20181004
008 201810s 0 0 eng d
022 _a1365-2133
024 7 _a10.1111/bjd.15947
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMurrell, D F
245 0 0 _aRituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus.
_h[electronic resource]
260 _bThe British journal of dermatology
_c11 2017
300 _a1143-1144 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aHumans
650 0 4 _aPemphigus
650 0 4 _aPrednisone
650 0 4 _aRituximab
700 1 _aSprecher, E
773 0 _tThe British journal of dermatology
_gvol. 177
_gno. 5
_gp. 1143-1144
856 4 0 _uhttps://doi.org/10.1111/bjd.15947
_zAvailable from publisher's website
999 _c27842329
_d27842329